title: Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats.
abstract: We investigated a possible beneficial role for bilirubin, one of the products of heme degradation by the cytoprotective enzyme heme oxygenase-1 in counteracting Escherichia coli endotoxin-mediated toxicity. Homozygous jaundice Gunn rats, which display high plasma bilirubin levels due to deficiency of glucuronyl transferase activity, and Sprague-Dawley rats subjected to sustained exogenous bilirubin administration were more resistant to endotoxin (LPS)-induced hypotension and death compared with nonhyperbilirubinemic rats. LPS-stimulated production of nitric oxide (NO) was significantly decreased in hyperbilirubinemic rats compared with normal animals; this effect was associated with reduction of inducible NO synthase (NOS2) expression in renal, myocardial, and aortic tissues. Furthermore, NOS2 protein expression and activity were reduced in murine macrophages stimulated with LPS and preincubated with bilirubin at concentrations similar to that found in the serum of hyperbilirubinemic animals. This effect was secondary to inhibition of NAD(P)H oxidase since 1) inhibition of NAD(P)H oxidase attenuated NOS2 induction by LPS, 2) bilirubin decreased NAD(P)H oxidase activity in vivo and in vitro, and 3) down-regulation of NOS2 by bilirubin was reversed by addition of NAD(P)H. These findings indicate that bilirubin can act as an effective agent to reduce mortality and counteract hypotension elicited by endotoxin through mechanisms involving a decreased NOS2 induction secondary to inhibition of NAD(P)H oxidase.
authors.affiliation: INSERM U 700 and U 683, Faculté de Médecine Xavier Bichat, Université Paris VII, Paris, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Lanone
authors.forename: Sébastien
authors.initials: S
authors.lastname: Bloc
authors.forename: Roberta
authors.initials: R
authors.lastname: Foresti
authors.forename: Abdelhamid
authors.initials: A
authors.lastname: Almolki
authors.forename: Camille
authors.initials: C
authors.lastname: Taillé
authors.forename: Jacques
authors.initials: J
authors.lastname: Callebert
authors.forename: Marc
authors.initials: M
authors.lastname: Conti
authors.forename: Delphine
authors.initials: D
authors.lastname: Goven
authors.forename: Michel
authors.initials: M
authors.lastname: Aubier
authors.forename: Bertrand
authors.initials: B
authors.lastname: Dureuil
authors.forename: Jamel
authors.initials: J
authors.lastname: El-Benna
authors.forename: Roberto
authors.initials: R
authors.lastname: Motterlini
authors.forename: Jorge
authors.initials: J
authors.lastname: Boczkowski
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D001011:Aorta / Q000201:enzymology / Q000378:metabolism; D001663:Bilirubin / Q000737:chemistry / Q000378:metabolism; D001794:Blood Pressure; D015153:Blotting, Western; D002460:Cell Line; D015536:Down-Regulation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004926:Escherichia coli / Q000378:metabolism; D005609:Free Radicals; D005979:Glutathione Peroxidase / Q000378:metabolism; D006418:Heme / Q000737:chemistry; D006720:Homozygote; D016753:Interleukin-10 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D007565:Jaundice / Q000473:pathology; D007668:Kidney / Q000201:enzymology / Q000378:metabolism; D008070:Lipopolysaccharides / Q000737:chemistry; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000737:chemistry; D051379:Mice; D008954:Models, Biological; D015233:Models, Statistical; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009566:Nitrates / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000096:biosynthesis* / Q000737:chemistry; D009573:Nitrites / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D051381:Rats; D011911:Rats, Gunn; D017207:Rats, Sprague-Dawley; D012772:Shock, Septic / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control*; D013482:Superoxide Dismutase / Q000378:metabolism; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D000975:Antioxidants; D004791:Enzyme Inhibitors; D005609:Free Radicals; D015850:Interleukin-6; D008070:Lipopolysaccharides; D009566:Nitrates; D009573:Nitrites; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D009569:Nitric Oxide; D006418:Heme; D008315:Malondialdehyde; D005979:Glutathione Peroxidase; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; D013482:Superoxide Dismutase; D019255:NADPH Oxidases; D048051:p38 Mitogen-Activated Protein Kinases; D001663:Bilirubin; D010100:Oxygen